GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Gland Pharma Ltd
Gland Pharma Ltd: Board Approves Final Dividend of Rs. 20/- Per Share
DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 15 May 2026, 04:46 PM IST  ·  BSE ID: 0ebe939b-0063-4747-bbbe-1baee286261e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has approved paying shareholders a final dividend of Rs. 20/- per share.
🤖 AI Summary
  • Gland Pharma Ltd Board approved a final dividend of Rs. 20/- per equity share for FY 2025-26.
  • The dividend approval is subject to shareholder approval at the ensuing 48th Annual General Meeting.
  • Record date for this final dividend has been set as August 11, 2026.
  • This follows an earlier intimation regarding the record date for the final dividend.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Share
Rs. 20/- per share
🏢 How This Affects the Company
💰
Financial Impact
The approved dividend payout will lead to an outflow of cash reserves from the company once disbursed.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must hold shares on or before the record date of August 11, 2026, to be eligible for the dividend.
👤
Who Is Affected
All shareholders of Gland Pharma Ltd holding equity shares on the record date will be eligible to receive a final dividend of Rs. 20/- per share.
🔍
Management Signal
This decision indicates management's intent to distribute a portion of earnings to shareholders, reflecting financial stability.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Outcome of 48th Annual General Meeting regarding dividend approval.
Company announcement confirming dividend payment post-AGM.
Future dividend declarations in subsequent financial periods.
LOW RISK The filing reports a standard corporate action; no new risks are introduced.
💡 Investor Takeaway
Gland Pharma Ltd's Board approved a final dividend of Rs. 20/- per equity share for FY 2025-26, pending shareholder approval at the 48th AGM. The record date for this dividend is August 11, 2026, confirming the timeline for eligible shareholders.
⚖️ Strengths & Concerns

✅ Positives

  • Consistent dividend approval reflects the company's established practice of returning value to shareholders.
  • The specific dividend amount of Rs. 20/- per share provides clarity on the immediate distribution.
📅 Company Track Record
Gland Pharma Ltd has previously announced dividend-related corporate actions. A filing on May 15, 2026, confirmed the record date for this final dividend for FY26 as August 11, 2026, preceding this current announcement of Board approval.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.